Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Urinary Bladder Neoplasms 2Glioblastoma 2Stomach Neoplasms 1Solitary Pulmonary Nodule 1Non-Muscle Invasive Bladder Neoplasms 1Multiple Pulmonary Nodules 1Medication Adherence 1Margins of Excision 1Lymphoma, Follicular 1Lung Neoplasms 1Glioma 1Esophageal Neoplasms 1Early-stage Peripheral Non-small Cell Lung Cancer 1Dementia 1Cognitive Dysfunction 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Brain Neoplasms 1Alzheimer Disease 1

Interventions

pembrolizumab 88Carboplatin 77Specimen Handling 76Magnetic Resonance Spectroscopy 63Pemetrexed 59Cisplatin 47durvalumab 44Paclitaxel 38Nivolumab 34atezolizumab 32osimertinib 29Radiotherapy 29Radiosurgery 29Biopsy 26Blood Specimen Collection 25Gemcitabine 24Docetaxel 24Immunoglobulin G 23Disulfides 22Standard of Care 21Drug Therapy 21Etoposide 19Taxes 18Practice Guidelines as Topic 18Radiation 17Educational Status 16130-nm albumin-bound paclitaxel 15X-Rays 14Surveys and Questionnaires 14Bevacizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Drug Delivery Systems × 1 year × Clear all
NCT06518655 2025-12-24

Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath

ChromX Health

Recruiting
3,000 enrolled
Thoracic

Solitary Pulmonary Nodule, Lung Neoplasms, Multiple Pulmonary Nodules

Data powered by HemOnc (CC BY 4.0) Colophon âš¡